Literature DB >> 27122518

Use of erythrocyte sedimentation rate and C-reactive protein to predict osteomyelitis recurrence.

Z Lin1, A Vasudevan1, P A Tambyah2.   

Abstract

PURPOSE: To determine the association between both erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) and osteomyelitis recurrence.
METHODS: Records of 81 males and 27 females aged 10 to 87 (median, 54) years who underwent antibiotic/ surgical treatment for primary (n=68) or recurrent (n=40) osteomyelitis that was related (n=26) or unrelated (n=82) to a prosthesis were reviewed. Of the 40 cases of osteomyelitis recurrence followed up for a median of 23.4 (range, 0.6-74.0) months, 7 and 33 were related and unrelated to a prosthesis, respectively. The cutoff points of lowest ESR and CRP for osteomyelitis recurrence were calculated. Risk factors for osteomyelitis recurrence were determined.
RESULTS: Osteomyelitis recurrence was associated with diabetes mellitus, ischaemic heart disease, non-healing wound, infection in the lower limb, and infection with methicillin-resistant Staphylococcus aureus. The cutoff points of CRP ≥5 mg/l and ESR ≥20 mm/h were used for osteomyelitis recurrence. Risk factors for osteomyelitis recurrence were ESR ≥20 mm/h, infection with methicillin-resistant S aureus, and infection in the lower limb.
CONCLUSION: ESR was more sensitive, specific, and independently associated with osteomyelitis recurrence and should be used to guide the duration of antibiotic treatment.

Entities:  

Keywords:  C-reactive protein; blood sedimentation; osteomyelitis; recurrence

Mesh:

Substances:

Year:  2016        PMID: 27122518     DOI: 10.1177/230949901602400118

Source DB:  PubMed          Journal:  J Orthop Surg (Hong Kong)        ISSN: 1022-5536            Impact factor:   1.118


  8 in total

1.  Plasma RANKL level is not a reliable marker to monitor the bone destruction in mice model of osteomyelitis.

Authors:  Hüsamettin Şen
Journal:  Jt Dis Relat Surg       Date:  2022-03-28

2.  The association of erythrocyte sedimentation rate, high-sensitivity C-reactive protein and diabetic kidney disease in patients with type 2 diabetes.

Authors:  Shizhe Guo; Meng Wang; Yifei Yu; Yeping Yang; Fangfang Zeng; Fei Sun; Qin Li; Min He; Yiming Li; Jie Wen; Wei Gong; Zhaoyun Zhang
Journal:  BMC Endocr Disord       Date:  2020-07-13       Impact factor: 2.763

3.  Factors predictive of relapse in adult bacterial osteomyelitis of long bones.

Authors:  E Garcia Del Pozo; J Collazos; J A Carton; D Camporro; V Asensi
Journal:  BMC Infect Dis       Date:  2018-12-07       Impact factor: 3.090

4.  First-4-week erythrocyte sedimentation rate variability predicts erythrocyte sedimentation rate trajectories and clinical course among patients with pyogenic vertebral osteomyelitis.

Authors:  Hsiu-Yin Chiang; Chih-Wei Chung; Chin-Chi Kuo; Yen-Chun Lo; Wei-Shuo Chang; Chih-Yu Chi
Journal:  PLoS One       Date:  2019-12-04       Impact factor: 3.752

5.  Delayed Diagnosis of Pediatric Sternoclavicular Joint Infections and Clavicular Osteomyelitis During the COVID-19 Pandemic: A Report of 3 Cases.

Authors:  Elizabeth M Benson; Ezan A Kothari; Timothy W Torrez; Michael J Conklin; Stephanie Berger; Kevin A Williams
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2022-09-27

6.  Native mitral valve infective endocarditis caused by Staphylococcus warneri: A case-based review.

Authors:  Ibuki Kurihara; Katsuyuki Yoshida; Takahiko Fukuchi; Hitoshi Sugawara
Journal:  Clin Case Rep       Date:  2021-07-21

7.  Extracellular Vesicles: A Potential Biomarker for Quick Identification of Infectious Osteomyelitis.

Authors:  Songyun Deng; Yutian Wang; Shiluan Liu; Te Chen; Yanjun Hu; Guangyan Zhang; Xianrong Zhang; Bin Yu
Journal:  Front Cell Infect Microbiol       Date:  2020-07-21       Impact factor: 5.293

8.  Promoting appropriate utilisation of laboratory tests for inflammation at an academic medical centre.

Authors:  Kristen J Bartlett; Ann P Vo; Justin Rueckert; Christina Wojewoda; Elizabeth H Steckel; Justin Stinnett-Donnelly; Allen B Repp
Journal:  BMJ Open Qual       Date:  2020-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.